BridgeBio Pharma, Inc. (BBIO) Options Statistics & Positioning

BridgeBio Pharma, Inc. (BBIO) options trade at a 30-day at-the-money implied volatility of 71.9%, an IV rank of 76 out of 100 over the past year. The options market prices a ±$15.27 (±18.8%) move in BBIO for the front expiration. Max pain sits at $75 and the put/call open interest ratio is 2.38. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close

$81.20

52-week range

$47.29 – $90.21

ATM IV (30d)

71.9%

IV rank

76 / 100

High

Expected move

±$15.27 (±18.8%)

Put/call OI

2.38

Put-heavy

Max pain

$75

↓ 7.6% below close

Next earnings

Nov 3, 2026

Most Active BBIO Contracts

Contract	Expiration	DTE	Last	IV	Volume
BBIO $45 put	Jan 15, 2027	144d	$0.50	—	2,150
BBIO $125 call	Jan 15, 2027	144d	$0.93	—	200
BBIO $135 call	Jan 15, 2027	144d	$0.48	—	200
BBIO $75 put	Sep 18, 2026	25d	$1.30	37.8%	109
BBIO $135 call	Feb 19, 2027	179d	$0.60	—	50

See all active BBIO contracts →

Explore BBIO Options Statistics

BBIO Implied Volatility

71.9% ATM IV (30d)

An IV rank of 76 places implied volatility near the top of its 52-week range.

Full implied volatility analysis →

BBIO Open Interest

2.38 put/call OI ratio

3,978 calls and 9,483 puts outstanding across all expirations.

Full open interest analysis →

BBIO Max Pain

$75 max pain

7.6% below the last close — see how max pain has moved over the past year.

Full max pain analysis →

BBIO Gamma Exposure

-$6.82M net GEX

Negative dealer gamma — hedging can currently amplify price swings.

Full gamma exposure analysis →

BBIO Options Volume

2,885 contracts traded

Put/call volume ratio 3.84 — plus contracts running far above their usual volume.

Full volume & flow analysis →

BBIO Most Active Options

$45 top volume strike

The 25 most actively traded BBIO contracts with price, IV, greeks, and volume vs. average.

Full active contracts analysis →

Upcoming Earnings

BBIO's next expected earnings date is Nov 3, 2026. Options currently price a ±$15.27 (±18.8%) move for the front expiration.

Explore the payoff profile of option on BBIO for free

Build multi-leg BBIO strategies, visualize payoffs, and scan the full US options universe with OptiView.

Open BBIO in the platform Scan options

BBIO Options FAQ

When is BBIO's next earnings date?

BBIO's next expected earnings date is Nov 3, 2026. Options currently price a ±$15.27 (±18.8%) move for the front expiration.

How often is BBIO options data on this page updated?

All BBIO statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see BBIO max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated BBIO pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.